Zacks de acciones de agtc
9/26/2019 · Applied Genetic Technologies (AGTC) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.37 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -13.73%. 11/8/2018 · Applied Genetic Technologies (AGTC) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.50 per share. This compares to loss of $0.08 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 114%. Obtenga información sobre la acción de Costco Wholesale Corp (COST): Precio, Gráficos, Análisis Técnico, Datos Históricos, Reportes de Costco Wholesale Corp y más. Zacks Equity Research - ZACKS - Tue Nov 12, 4:55PM CST Applied Genetic Technologies (AGTC) delivered earnings and revenue surprises of -10.34% and -100.00%, respectively, for the quarter ended September 2019. En Yahoo Finanzas, obtienes cotizaciones gratuitas de acciones, noticias actualizadas, recursos de administración de la cartera, datos de mercados internacionales, interacción social y tasas hipotecarias que te ayudan a administrar tu vida financiera. 5/7/2019 · Applied Genetic Technologies (AGTC) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of a loss of $0.54 per share. This compares to loss of $0.45 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 216.67%. Get breaking news and analysis on Applied Genetic Technologies Corporation (AGTC) stock, price quote and chart, trading and investing tools.
En AGTC buscamos nuevos sujetos para las pruebas de mejora de nuestros nuevos sistemas. Para separar el grano de la paja reaalizamos nuestra prueba de aptitud. En ella mediante diferentes experiencias valoramos los conocimientos de los individuos y dependiendo de los resultados obtenidos podrás formar una pequeña parte de este nuestro gran proyecto.
Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. 9/8/2010 · Opere en largo o corto en más de 8000 precios de acciones y obtenga una mayor flexibilidad con el acceso directo al mercado. Descubra más información Encuentra la cotización más reciente, historial, noticias y otra información vital de Applied Genetic Technologies Co (AGTC) para ayudarte con tus inversiones e Applied Genetic Technologies (AGTC) Reports Q1 Loss, Lags Revenue Estimates Applied Genetic Technologies (AGTC) delivered earnings and revenue surprises of -10.34% and -100.00%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Applied Genetic Technologies (AGTC) Reports Q1 Loss, Lags Revenue Estimates Applied Genetic Technologies (AGTC) delivered earnings and revenue surprises of -10.34% and -100.00%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Consulta las últimas cotizaciones de acciones, historial, noticias y otra información vital de Applied Genetic Technologies Co (AGTC) para ayudarte con tus
En Yahoo Finanzas, obtienes cotizaciones gratuitas de acciones, noticias actualizadas, recursos de administración de la cartera, datos de mercados internacionales, interacción social y tasas hipotecarias que te ayudan a administrar tu vida financiera.
Descubre los accionistas directos, los accionistas institucionales y los accionistas de fondos de inversión de Applied Genetic Technologies Co (AGTC).
View Grupo Aval Acciones y Valores S.A. AVAL investment & stock information. Get the latest Grupo Aval Acciones y Valores S.A. AVAL detailed stock quotes,
AGTC: Applied Genetic Technologies Corporation broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research. Analysts Estimate Applied Genetic Technologies (AGTC) to Report a Decline in Earnings: What to Look Out for Zacks-5.00% Sep-18-19 04:05PM AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 26, 2019 GlobeNewswire The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style. We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating: AGTC: Applied Genetic Technologies Corporation broker recommendations. Get the latest broker recommendations from Zacks Investment Research.
9/19/2019 · For Applied Genetic Technologies, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -17.65%. On the other hand, the stock currently carries a Zacks Rank of #3. 9/26/2019 · Applied Genetic Technologies (AGTC) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.37 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -13.73%. 11/8/2018 · Applied Genetic Technologies (AGTC) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.50 per share. This compares to loss of $0.08 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 114%.